Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.36T | 2.38T | 2.27T | 2.10T | 2.01T | 1.91T | Gross Profit |
575.09B | 593.13B | 526.68B | 450.44B | 397.92B | 469.74B | EBIT |
384.80B | 339.69B | 305.40B | 244.98B | 203.77B | 280.62B | EBITDA |
450.79B | 473.42B | 430.70B | 356.48B | 301.97B | 372.05B | Net Income Common Stockholders |
202.21B | 224.65B | 197.00B | 176.99B | 129.58B | 183.97B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
239.69B | 189.81B | 144.26B | 156.23B | 199.64B | 190.31B | Total Assets |
9.82T | 9.49T | 8.84T | 8.21T | 7.74T | 7.40T | Total Debt |
4.94T | 4.43T | 4.05T | 3.67T | 3.62T | 3.48T | Net Debt |
4.70T | 4.25T | 3.91T | 3.52T | 3.43T | 3.30T | Total Liabilities |
6.69T | 6.25T | 5.81T | 5.29T | 5.09T | 4.91T | Stockholders Equity |
3.01T | 3.11T | 2.90T | 2.80T | 2.56T | 2.41T |
Cash Flow | Free Cash Flow | ||||
0.00 | 20.86B | -65.04B | 29.90B | -88.47B | -386.72B | Operating Cash Flow |
0.00 | 241.70B | 297.71B | 271.47B | 187.86B | 87.09B | Investing Cash Flow |
0.00 | -286.99B | -422.03B | -210.06B | -131.03B | -532.81B | Financing Cash Flow |
0.00 | 59.99B | 111.45B | -139.60B | -66.56B | 467.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $758.63B | 8.37 | 18.00% | 2.52% | 10.51% | -9.28% | |
79 Outperform | ¥3.82T | 15.45 | 7.82% | 2.16% | 10.16% | 11.31% | |
78 Outperform | $761.40B | 9.74 | 9.70% | 3.27% | 4.28% | 12.70% | |
71 Outperform | $3.32T | 17.52 | 7.53% | 1.52% | 4.99% | 14.16% | |
71 Outperform | $1.10T | 11.26 | 21.32% | 3.91% | 6.40% | 28.80% | |
69 Neutral | $641.99B | 44.68 | 2.92% | 1.64% | 6.28% | -30.10% | |
61 Neutral | $2.82B | 10.89 | 0.42% | 8438.96% | 5.74% | -20.95% |
Mitsui Fudosan Co., Ltd. announced that it did not repurchase any shares during the period from May 1, 2025, to May 31, 2025, despite having a board-approved plan to repurchase up to 50 million shares by January 31, 2026. This indicates a cautious approach in executing its share buyback strategy, which could impact its stock market performance and shareholder value.
The most recent analyst rating on (JP:8801) stock is a Hold with a Yen1500.00 price target. To see the full list of analyst forecasts on Mitsui Fudosan Co stock, see the JP:8801 Stock Forecast page.
Mitsui Fudosan Co., Ltd. announced a correction to its previously disclosed financial results for the fiscal year 2024. The correction involves a slight adjustment in the Return on Assets (ROA) from 4.01% to 4.12%, reflecting a more favorable financial performance than initially reported. This correction may impact stakeholders’ perception of the company’s financial health and operational efficiency.
The most recent analyst rating on (JP:8801) stock is a Hold with a Yen1500.00 price target. To see the full list of analyst forecasts on Mitsui Fudosan Co stock, see the JP:8801 Stock Forecast page.
Mitsui Fudosan Co., Ltd. announced a resolution to increase its fiscal year-end dividend per share to 31.00 yen, which is 1.00 yen higher than the previous forecast. This decision aligns with the company’s shareholder return policy and reflects its consolidated financial results for the fiscal year ended March 31, 2025. The increase in dividends is subject to approval at the upcoming Annual Meeting of Shareholders. The company also conducted a 3-for-1 stock split, affecting the dividend calculations for the fiscal year.
Mitsui Fudosan Co., Ltd. reported a significant increase in its consolidated financial results for the fiscal year ended March 31, 2025, with a 10.2% rise in revenue from operations and a 9.7% increase in operating income. Despite a decrease in comprehensive income by 51.2%, the company maintained a steady return on equity and improved its basic earnings per share following a three-for-one stock split. The announcement indicates a robust operational performance, although the decline in comprehensive income may prompt stakeholders to scrutinize the underlying factors.
Mitsui Fudosan Co., Ltd. announced that no shares were repurchased during April 2025, despite a board resolution allowing for the repurchase of up to 50 million shares. The company had previously repurchased over 1.6 million shares by the end of April 2025, reflecting its strategy to manage capital and enhance shareholder value.
Mitsui Fudosan Co., Ltd. announced the repurchase of 1,430,400 of its common shares for a total of 1,780,332,350 yen, conducted through open market purchases on the Tokyo Stock Exchange during March 2025. This move is part of a broader share repurchase program approved by the board, allowing for the repurchase of up to 50 million shares, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
Mitsui Fudosan Co., Ltd. announced a revision to its stock compensation system for directors, excluding outside directors, as part of a broader review of its officer compensation strategy. This revision, aligned with the company’s Long-Term Vision & INNOVATION 2030, aims to enhance corporate value and shareholder engagement by introducing restricted stock units (RSUs) to secure funds for tax liabilities when transfer restrictions on restricted stock are lifted.